Literature DB >> 1643164

Reversible bone marrow aplasia induced by naproxen.

S M Sanal1, M Gur-Lavi.   

Abstract

We report a case of reversible bone marrow aplasia related to the use of naproxen. A 71-year-old women developed severe pancytopenia after she had been treated with naproxen for more than 8 weeks. Bone marrow examination showed marked hypocellularity compatible with aplastic anemia. Full recovery of the pancytopenia and bone marrow was observed when naproxen was discontinued. Absence of exposure to other drugs and lack of underlying disorders known to cause bone marrow aplasia makes this case unique.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1643164     DOI: 10.1007/bf01715130

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  6 in total

1.  Letter: Agranulocytosis and aplastic anemia possibly due to ibuprofen.

Authors:  C I Gryfe
Journal:  Can Med Assoc J       Date:  1976-05-22       Impact factor: 8.262

2.  Aplastic anaemia associated with a non-steroidal anti-inflammatory drug: relapse after exposure to another such drug.

Authors:  R Andrews; N Russell
Journal:  BMJ       Date:  1990-07-07

3.  Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone.

Authors:  W H Inman
Journal:  Br Med J       Date:  1977-06-11

4.  Naproxen-associated aplastic anaemia.

Authors:  P McNeil; I MacKenzie; A Manoharan
Journal:  Med J Aust       Date:  1986-07-07       Impact factor: 7.738

5.  Ibuprofen-associated pure white-cell aplasia.

Authors:  S W Mamus; J D Burton; J D Groat; D A Schulte; M Lobell; E D Zanjani
Journal:  N Engl J Med       Date:  1986-03-06       Impact factor: 91.245

6.  Marrow aplasia and sulindac.

Authors:  J L Miller
Journal:  Ann Intern Med       Date:  1980-01       Impact factor: 25.391

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.